Navega Therapeutics, Inc.
CIK 2107977 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Navega Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Jan 30, 2026 | D | 0002107977-26-000001 |